- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00001574
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
Brain tumors represent the most common solid tumor of childhood. Treatment generally entails surgery and radiation, but local recurrence is frequent. Chemotherapy is often used in an adjuvant setting, to delay radiation therapy or for resistant disease. Children with brain tumors are generally followed by imaging studies, such as CT or MRI. Difficulty arises in trying to distinguish tumor regrowth from treatment related edema, necrosis or radiation injury. Proton Nuclear Magnetic Resonance Spectroscopic (NMRS) Imaging is a non-invasive method of detecting and measuring cellular metabolites in vivo. NMRS imaging complements routine MRI by giving chemical information in conjunction with spatial information obtained by MRI.
This study will be conducted to determine NMRS imaging patterns before, during and after chemotherapy in pediatric patients with primary or metastatic brain tumors in an attempt to identify and characterize specific patterns of metabolites related to tumor regrowth, tumor response to therapy, edema or necrosis.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Background:
- Brain tumors represent the most common solid tumor of childhood. Treatment generally includes surgery and radiation, but recurrences are frequent, particularly for high-grade lesions.
- Chemotherapy is often used in an adjuvant setting, to delay radiation therapy or for resistant disease.
- Children with brain tumors are generally followed by imaging studies, such as CT or MRI.
- Difficulty arises in trying to distinguish tumor regrowth from treatment related edema, necrosis or radiation injury.
- Proton Nuclear Magnetic Resonance Spectroscopic (NMRS) Imaging is a non-invasive method of detecting and measuring cellular metabolites in vivo.
Objective:
- To determine NMRS imaging patterns before, during and after chemotherapy in pediatric patients with primary or metastatic brain tumors
- To identify and characterize specific patterns of metabolites related to tumor regrowth, tumor response to therapy, edema or necrosis.
Eligibility:
- Age less than or equal to 21 years.
- Patients entered on this trial will also be entered on one of the Branch s primary brain tumor treatment trials.
- Histologically confirmed primary or metastatic brain tumor. Patients with a brainstem glioma or optic pathway gliomas are not required to have a histologic diagnosis.
- Measurable or evaluable tumor at the time of study entry.
Design:
- This is intended to be a pilot study to define metabolite patterns associated with tumor growth, tumor edema and tumor necrosis as seen on standard MRI; and determine the feasibility of using metabolite patterns to predict response to therapy in pediatric patients with brain tumors.
- Contalateral spectroscopic analysis of normal appearing brain will also be performed when feasible.
- Analysis of results will be stratified according to type of tumor, and prior history of radiation therapy or surgery.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Maryland
-
Bethesda, Maryland, Förenta staterna, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
- INCLUSION CRITERIA:
Age less than or equal to 21 years.
Patients entered on this trial will also be entered on one of the Pediatric Oncology Branch's primary treatment trials (e.g., phenylacetate, phenylbutyrate, SU-101) or on the Natural History or Standard Therapy protocols. The patient's management will be determined by the primary treatment protocol.
Histology confirmed primary or metastatic brain tumor. Patients with a brainstem glioma are not required to have previously had a histologic diagnosis.
Measurable or evaluable tumor at the time of study entry.
Durable Power of Attorney (DPA): A DPA is required of all patients 18 - 21 years of age.
All patients or their legal guardians (if the patient is less than 18 years of age) must sign a document of informed consent indicating their awareness of the investigational nature and the risks of this study. When appropriate the minor patient will give verbal assent.
EXCLUSION CRITERIA:
Pregnant women.
Any patient who is unable (either because of physical or psychological factors) to undergo imaging studies and who is not an anesthesia candidate.
Any patient with a metallic implant, including cardiac pacemakers, neural pacemakers, shrapnel, cochlear implants or ferrous surgical clips.
Any patient with a history of a severe reaction to Gadolinium or other contrast agents.
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
To define specific patterns of metabolises using long-echo time multislice proton nuclear magnetic resonance spectroscopic imaging in pediatric patients with brain tumors.
Tidsram: at time of disease evaluation
|
in vivo measurements of tissue metabolites (NAA, Cho,Cr, Lac) and what they reflect
|
at time of disease evaluation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Distinguish spectroscopic patterns associated with tumor progression, necrosis and edema
Tidsram: at time of disease evaluation
|
measurements and differences of signal intensity of peaks obtained for tissue metabolites (NAA, Cho, Cr, Lac)
|
at time of disease evaluation
|
Determine if early metabolic changes are predictive of response
Tidsram: at time of disease evaluation
|
Contalateral spectroscopic analysis results, stratified according to type of tumor, history of radiation therapy or surgery
|
at time of disease evaluation
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996 Jan;17(1):1-15. No abstract available.
- Sutton LN, Wang Z, Gusnard D, Lange B, Perilongo G, Bogdan AR, Detre JA, Rorke L, Zimmerman RA. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery. 1992 Aug;31(2):195-202. doi: 10.1227/00006123-199208000-00004.
- Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology. 1993 Jul;188(1):277-82. doi: 10.1148/radiology.188.1.8511313.
Studieavstämningsdatum
Studera stora datum
Studiestart
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 970093
- 97-C-0093
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Hjärncancer
-
Assistance Publique Hopitaux De MarseilleOkänd
-
University of California, Los AngelesApplied BioClinical Inc.AvslutadKognitiv funktion | Påverka | Brain-derived neurotrophic factor (BDNF)Förenta staterna
-
National Council of Scientific and Technical Research...Medical School HamburgRekryteringHjärnrespons framkallad av radiofrekvensstimuli hos människor | Brain Response Voked by Pinprick Stimuli in HumansArgentina
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)AvslutadChildhood Brain Neoplasm | Återkommande Childhood Brain NeoplasmFörenta staterna
-
University of MichiganAvslutadFörändringar i Brain Network ConnectivityFörenta staterna
-
Assiut UniversityAvslutad
-
University of Alabama at BirminghamRekryteringHypertoni | BMI | Träning | Brain Care PoängFörenta staterna
-
University of CalgaryHar inte rekryterat ännuStroke/Brain AttackKanada
-
Izmir Katip Celebi UniversityThe Scientific and Technological Research Council of TurkeyRekryteringStroke | Stroke, ischemisk | Stroke/Brain AttackKalkon
-
Johns Hopkins UniversityAmerican Heart Association; University of Maryland, College ParkRekryteringStroke | Stroke följdsjukdomar | Stroke/Brain AttackFörenta staterna